The largest database of trusted experimental protocols

Polarstar omega plate

Manufactured by BMG Labtech
Sourced in Germany

The POLARstar Omega is a multimode microplate reader from BMG LABTECH. It is designed to perform various detection methods, including absorbance, fluorescence intensity, luminescence, and time-resolved fluorescence. The instrument provides accurate and reliable data for a wide range of applications in life science research and drug discovery.

Automatically generated - may contain errors

16 protocols using polarstar omega plate

1

Antifungal Susceptibility Assay for Candida albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fungus Candida albicans ATCC 10,231 was streaked onto a tryptic soy agar plate and incubated at 37 °C for 48 h. One colony was then transferred to fresh tryptic soy broth (5 mL) and the cell density was adjusted to 104–105 CFU/mL. Analytes (compounds) to be tested were dissolved in DMSO and diluted with H2O to give a stock solution (600 μM in 20% DMSO), which was serially diluted with 20% DMSO to give concentrations from 600 μM to 0.2 μM in 20% DMSO. An aliquot (10 mL) of each dilution was transferred to a 96-well microtiter plate and freshly prepared fungal broth (190 μL) was added to each well to give final analyte concentrations ranging from 30 to 0.01 μM in 1% DMSO. The plates were incubated at 37 °C for 24 h and the optical density of each well measured spectrophotometrically at 600 nm using a POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Ketoconazole B was used as a positive control (30 μM in 1% DMSO). Where relevant, IC50 value were calculated as the concentration of the compound or antifungal drug required for 50% inhibition of the fungal cells using Prism 8.0 (GraphPad Software Inc., La Jolla, CA, USA) (Figure S49).
+ Open protocol
+ Expand
2

Antifungal Activity Screening of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fungus Candida albicans ATCC 10231 was streaked onto a Sabouraud agar plate and was incubated at 37 °C for 48 h. One colony was then transferred to fresh Sabouraud broth (15 mL) and the cell density adjusted to 104–105 CFU/mL. Test compounds were dissolved in DMSO and diluted with H2O to give a 600 µM stock solution (20% DMSO), which was serially diluted with 20% DMSO to give concentrations from 600 to 0.2 µM in 20% DMSO. An aliquot (10 µL) of each dilution was transferred to a 96-well microtiter plate and freshly prepared fungal broth (190 µL) was added to each well to give final concentrations of 30 to 0.01 µM in 1% DMSO. The plates were incubated at 37 °C for 24 h and the optical density of each well was measured spectrophotometrically at 600 nm using POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Ketoconazole was used as a positive control (30 µg/mL in 10% DMSO). Where relevant, IC50 value were calculated as the concentration of the compound or antifungal drug required for 50% inhibition of the fungal cells using Prism 7.0 (GraphPad Software Inc., La Jolla, CA, USA).
+ Open protocol
+ Expand
3

Antibacterial Activity Screening of N-amino Anthranilic Acid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterium to be tested was streaked onto a tryptic soy agar plate and was incubated at 37 °C for 24 h. One colony was then transferred to fresh tryptic soy broth (5 mL), and the cell density was adjusted to 104–105 CFU/mL. N-amino anthranilic acid was dissolved in DMSO and diluted with H2O to give 600 μM stock solution (20% DMSO), which was serially diluted with 20% DMSO to give concentrations from 600 μM to 0.2 μM in 20% DMSO. An aliquot (10 μL) of each dilution was transferred to a 96-well microtiter plate, and freshly prepared microbial broth (190 μL) was added to each well to give final concentrations of 30–0.01 μM in 1% DMSO. The plates were incubated at 37 °C for 24 h, and the optical density (OD) of each well was measured spectrophotometrically at 600 nm using POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Each test compound was screened against the Gram-negative bacterium Escherichia coli ATCC11775 and the Gram-positive bacteria Staphylococcus aureus ATCC25923 and Bacillus subtilis ATCC6633. A mixture of rifampicin and ampicillin was used as a positive control (30 μM in 20% DMSO). The IC50 value was calculated as the concentration of the compound or antibiotic required for 50% inhibition of the bacterial cells using Prism 8.0 (GraphPad Software Inc., La Jolla, CA, USA) (Figure S26).
+ Open protocol
+ Expand
4

Antifungal Activity Screening of Compounds against Candida albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fungus Candida albicans ATCC 10231 was streaked onto a LB (Luria–Bertani) agar plate and was incubated at 37 °C for 48 h, after which a colony was transferred to fresh LB broth (15 mL) and the cell density was adjusted to 104–105 CFU/mL. Test compounds were dissolved in DMSO and diluted with H2O to prepare 600 µM stock solutions (20% DMSO), which were serially diluted with 20% DMSO to provide concentrations from 600 µM to 0.2 µM in 20% DMSO. An aliquot (10 µL) of each dilution was transferred to a 96-well microtiter plate and freshly prepared fungal broth (190 µL) was added to prepare final concentrations of 30–0.01 µM in 1% DMSO. The plates were incubated at 27 °C for 48 h and the optical density of each well was measured spectrophotometrically at 600 nm using POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Amphotericin B was used as the positive control (40 µg/mL in 10% DMSO). The IC50 value was calculated as the concentration of the compound or antibiotic required for 50% inhibition of the bacterial cells using Prism 7.0 (GraphPad Software Inc., La Jolla, CA, USA). See Figure S80.
+ Open protocol
+ Expand
5

Antifungal Activity Screening of Test Compounds against Candida albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fungus Candida albicans ATCC 10231 was streaked onto a Sabouraud agar plate and was incubated at 37 °C for 48 h. One colony was then transferred to fresh Sabouraud broth (15 mL) and the cell density adjusted to 104–105 CFU/mL. Test compounds were dissolved in DMSO and diluted with H2O to give a 600 µM stock solution (20% DMSO), which was serially diluted with 20% DMSO to give concentrations from 600 µM to 0.2 µM in 20% DMSO. An aliquot (10 µL) of each dilution was transferred to a 96-well microtiter plate and freshly prepared fungal broth (190 µL) was added to each well to give final concentrations of 30–0.01 µM in 1% DMSO. The plates were incubated at 37 °C for 24 h and the optical density of each well was measured spectrophotometrically at 600 nm using a POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Ketoconazole was used as a positive control (30 µg/ml in 10% DMSO). Where relevant, IC50 values were calculated as the concentration of the compound or antifungal drug required for 50% inhibition of the fungal cells using Prism 7.0 (GraphPad Software Inc., La Jolla, CA, USA) (Figure S67).
+ Open protocol
+ Expand
6

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterium to be tested was streaked onto a tryptic soy agar plate and incubated at 28 °C or 37 °C for 24 h. One colony was then transferred to fresh tryptic soy broth (Difco, USA) (15 mL) and the cell density was adjusted to 104–105 colony-forming units (cfu)/mL. Test extracts were dissolved in 100% dimethyl sulfoxide (DMSO) and diluted with sterilised deionised water to 10% DMSO. The stock solution was diluted with 10% DMSO to give final concentrations of 1% DMSO. The extract concentrations were then serially diluted to 500, 250, 150, and 100 µg extracts/mL of 1% DMSO. Each dilution was transferred to a 96-well microtiter plate and freshly prepared microbial broth was added to each well. Negative growth controls contained only growth media, and positive growth controls contained growth media and bacterial suspension. The plates were incubated at 37 °C for 24 h, and the optical density of each well was measured spectrophotometrically at 600 nm (using POLARstar Omega Plate, BMG LABTECH, Offenburg, Germany). MIC values were determined after overnight incubation and recorded as the lowest concentration of each test solution that inhibited the growth of all the microorganisms in the wells. The experiments were conducted in triplicate for each sample and the average concentration of each triplicate was calculated.
+ Open protocol
+ Expand
7

Cell Viability Assay with CellTiterGlo

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 96-well plates with indicated concentrations of respective compounds and plates were incubated at 37 °C for 96 h. Readout was performed with CellTiterGlo® Luminescent Cell Viability Assay (Promega) according to the manufacturer’s protocol and luminescence was measured with POLARStar Omega plate reader (BMG LabTech). All results were normalized to non-treated conditions and data represent mean ± SD of biological triplicates.
+ Open protocol
+ Expand
8

Antifungal Activity Evaluation of N-amino Anthranilic Acid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fungus Candida albicans ATCC 10231 was streaked onto a tryptic soy agar plate and was incubated at 37 °C for 48 h. One colony was then transferred to fresh tryptic soy broth (5 mL), and the cell density was adjusted to 104–105 CFU/mL. N-amino anthranilic acid was dissolved in DMSO and diluted with H2O to give a 600 μM stock solution (20% DMSO), which was serially diluted with 20% DMSO to give concentrations from 600 μM to 0.2 μM in 20% DMSO. An aliquot (10 μL) of each dilution was transferred to a 96-well microtiter plate, and freshly prepared fungal broth (190 μL) was added to each well to give final concentrations of 30–0.01 μM in 1% DMSO. The plates were incubated at 37 °C for 24 h, and the optical density (OD) of each well was measured spectrophotometrically at 600 nm using POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Amphotericin B was used as a positive control (30 μg/mL in 20% DMSO). Where relevant, IC50 value were calculated as the concentration of the compound or antifungal drug required for 50% inhibition of the fungal cells using Prism 8.0 (GraphPad Software Inc., La Jolla, CA, USA) (Figure S26).
+ Open protocol
+ Expand
9

Antifungal activity screening of C. albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fungus C. albicans ATCC10231 was streaked onto a Sabouraud agar plate and was incubated
at 37 °C for 48 h. One colony was then transferred to fresh Sabouraud
broth (15 mL) and the cell density adjusted to 104–105 CFU/mL. For the single data point experiments, an aliquot
(10 μL) from 600 μM stock solution (20% DMSO) was transferred
to a 96-well microtiter plate, and freshly prepared fungal broth (190
μL) was added to each well to give final concentrations of 30
μM in 1% DMSO. The plates were incubated at 37 °C for 24
h, and the optical density of each well was measured spectrophotometrically
at 600 nm using a POLARstar Omega plate (BMG LABTECH, Offenburg, Germany).
Ketoconazole was used as a positive control (30 μg/mL in 10%
DMSO). Where relevant, IC50 values were calculated as the
concentration of the compound or antifungal drug required for 50%
inhibition of the fungal cells using Prism 7.0 (GraphPad Software
Inc., La Jolla, CA).
+ Open protocol
+ Expand
10

Antimicrobial Susceptibility Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterium to be tested was streaked onto a tryptic soy agar plate and incubated at 37 °C for 24 h. One colony was then transferred to fresh tryptic soy broth (15 mL) and the cell density adjusted to 104–105 CFU/mL. The compounds to be tested were dissolved in DMSO and diluted with H2O to return 600 µM stock solutions (20% DMSO). The stock solutions were serially diluted to give concentration range of 600 µM to 0.2 µM in 20% DMSO/H2O. An aliquot (10 µL) of each dilution was transferred to a 96-well microtiter plate and freshly prepared microbial broth (190 µL) was added to each well. The plates were incubated at 37 °C for 24 h and the optical density of each well was measured spectrophotometrically at 600 nm using POLARstar Omega plate (BMG LABTECH, Offenburg, Germany). Each test compound was screened against the Gram-negative bacterium Escherichia coli (ATCC 11775) and the Gram-positive bacterium Bacillus subtilis (ATCC 6051). Rifampicin was used as a positive control (40 µg/mL in 10% DMSO). The IC50 value was calculated as the concentration of the compound or antibiotic required for 50% inhibition of the bacterial cells using Prism 7.0 from GraphPad Software Inc. (La Jolla, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!